Christophe Parsy

Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor

Cyril B. Dousson, François-René Alexandre, Agnès Amador et al. · Journal of Medicinal Chemistry · 2016 · 72 citations

Medicinal Chemistry, Drug Resistant Virus, Medicine +13

A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E

Laurence Jonard, Delphine Feldmann, Christophe Parsy et al. · European Journal of Medical Genetics · 2007 · 57 citations

Mendelian Disorder, Genetic Disorder, Inherited Metabolic Disease +8

N,N-Dialkylalloxans—a new class of catalyst for dioxirane epoxidations

Andrew J. Carnell, R. A. W. Johnstone, Christophe Parsy et al. · Tetrahedron Letters · 1999 · 43 citations

Engineering, Dioxirane Epoxidations, Organic Chemistry +3

The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors

François-René Alexandre, Eric Badaroux, John P. Bilello et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 32 citations · Full text

Medicine, Antiviral Drug Development, Antiviral Therapy +9

Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320

Christophe Parsy, François-René Alexandre, Valérie Bidau et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 26 citations

Virus Structure, Medicine, Natural Sciences +11